These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35607987)

  • 1. Parkinson's Disease Is Associated with Impaired Gut-Blood Barrier for Short-Chain Fatty Acids.
    Yang X; Ai P; He X; Mo C; Zhang Y; Xu S; Lai Y; Qian Y; Xiao Q
    Mov Disord; 2022 Aug; 37(8):1634-1643. PubMed ID: 35607987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson's disease.
    Huang P; Zhang P; Du J; Gao C; Liu J; Tan Y; Chen S
    NPJ Parkinsons Dis; 2023 Jul; 9(1):115. PubMed ID: 37460569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's Disease.
    He X; Qian Y; Xu S; Zhang Y; Mo C; Guo W; Yang X; Xiao Q
    J Parkinsons Dis; 2021; 11(3):1167-1176. PubMed ID: 33935107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Short-Chain Fatty Acids in Patients With Parkinson's Disease.
    Shin C; Lim Y; Lim H; Ahn TB
    Mov Disord; 2020 Jun; 35(6):1021-1027. PubMed ID: 32154946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and comparison of short chain fatty acids composition in gut diseases.
    Niccolai E; Baldi S; Ricci F; Russo E; Nannini G; Menicatti M; Poli G; Taddei A; Bartolucci G; Calabrò AS; Stingo FC; Amedei A
    World J Gastroenterol; 2019 Sep; 25(36):5543-5558. PubMed ID: 31576099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.
    Wu G; Jiang Z; Pu Y; Chen S; Wang T; Wang Y; Xu X; Wang S; Jin M; Yao Y; Liu Y; Ke S; Liu S
    BMC Neurol; 2022 Jan; 22(1):13. PubMed ID: 34996385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
    Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
    Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson's Disease (PD).
    Du J; Zhang P; Tan Y; Gao C; Liu J; Huang M; Li H; Shen X; Huang P; Chen S
    Mov Disord; 2024 Aug; 39(8):1397-1402. PubMed ID: 38561921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
    Aho VTE; Houser MC; Pereira PAB; Chang J; Rudi K; Paulin L; Hertzberg V; Auvinen P; Tansey MG; Scheperjans F
    Mol Neurodegener; 2021 Feb; 16(1):6. PubMed ID: 33557896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A High Salt Diet Modulates the Gut Microbiota and Short Chain Fatty Acids Production in a Salt-Sensitive Hypertension Rat Model.
    Bier A; Braun T; Khasbab R; Di Segni A; Grossman E; Haberman Y; Leibowitz A
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30142973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Fecal Short-Chain Fatty Acids (SCFAs) in Healthy Children during the First Two Years of Life: An Observational Prospective Cohort Study.
    Łoniewska B; Fraszczyk-Tousty M; Tousty P; Skonieczna-Żydecka K; Maciejewska-Markiewicz D; Łoniewski I
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
    Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
    Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy.
    Chai L; Luo Q; Cai K; Wang K; Xu B
    BMC Nephrol; 2021 Jun; 22(1):209. PubMed ID: 34082732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel LCMSMS method for quantitative measurement of short-chain fatty acids in human stool derivatized with
    Chan JC; Kioh DY; Yap GC; Lee BW; Chan EC
    J Pharm Biomed Anal; 2017 May; 138():43-53. PubMed ID: 28178633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC-MS.
    Hsu YL; Chen CC; Lin YT; Wu WK; Chang LC; Lai CH; Wu MS; Kuo CH
    J Proteome Res; 2019 May; 18(5):1948-1957. PubMed ID: 30895795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors.
    Nomura M; Nagatomo R; Doi K; Shimizu J; Baba K; Saito T; Matsumoto S; Inoue K; Muto M
    JAMA Netw Open; 2020 Apr; 3(4):e202895. PubMed ID: 32297948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between fecal short-chain fatty acid levels and constipation severity in subjects with slow transit constipation.
    Chen Q; Chen D; Gao X; Jiang Y; Yu T; Jiang L; Tang Y
    Eur J Gastroenterol Hepatol; 2024 Apr; 36(4):394-403. PubMed ID: 38417059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of Sanhua decoction on rats with middle cerebral artery occlusion and the associated changes in gut microbiota and short-chain fatty acids.
    Ni Y; Cai L; Gou X; Li W; Zhou M; Huang Y
    PLoS One; 2024; 19(2):e0298148. PubMed ID: 38363776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.